The Gross Law Firm Notifies Shareholders of Marinus Pharmaceuticals, Inc.(MRNS) of a Class Action Lawsuit and an Upcoming Deadline

Core Viewpoint - Marinus Pharmaceuticals, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding the risks associated with their clinical trials, specifically the RAISE trial and its implications for the RAISE II trial [2]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as March 17, 2021, to May 7, 2024 [2]. - Allegations include that the defendants understated the risk of failing to meet early-stopping criteria in the RAISE trial and did not disclose the potential consequences of such failure, which could lead to stopping the RAISE II trial [2]. Group 2: Shareholder Actions - Shareholders who purchased MRNS shares during the class period are encouraged to register for the class action, with a deadline set for August 5, 2024 [3]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].